Positive Impact of a Point-of-Care Molecular Influenza Test in the Emergency Department During the 2017-2018 Seasonal Influenza Epidemic.

influenza nucleic-acid amplification test oseltamivir point of care seasonal flu

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
01 Jul 2019
Historique:
received: 01 05 2019
accepted: 26 06 2019
entrez: 1 8 2019
pubmed: 1 8 2019
medline: 1 8 2019
Statut: ppublish

Résumé

During the 2017-2018 flu epidemic, the point-of-care Alere-i (n = 72) and reverse transcription polymerase chain reaction (n = 106) tests were compared. Patients in the point-of-care group were administered oseltamivir significantly more rapidly (9 hours vs 23 hours), they spent less time in the emergency department, and they had lower rates of antibiotic administration and hospitalization.

Identifiants

pubmed: 31363768
pii: 5541691
doi: 10.1093/ofid/ofz312
pmc: PMC6667710
pii:
doi:

Types de publication

Journal Article

Langues

eng

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

Pediatrics. 2003 Aug;112(2):363-7
pubmed: 12897288
Clin Infect Dis. 2009 Apr 15;48(8):1003-32
pubmed: 19281331
J Antimicrob Chemother. 2011 May;66(5):959-63
pubmed: 21406435
Med Mal Infect. 2014 Mar;44(3):123-7
pubmed: 24612505
J Infect Dis. 2015 Nov 15;212(10):1604-12
pubmed: 25941330
Ann Intern Med. 2017 Sep 19;167(6):394-409
pubmed: 28869986
Intensive Care Med. 2018 Feb;44(2):257-260
pubmed: 29026934
Clin Infect Dis. 2018 Mar 19;66(7):1035-1041
pubmed: 29069334
J Infect Dis. 2017 Nov 15;216(8):936-944
pubmed: 29149338
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Diagn Microbiol Infect Dis. 2018 Mar;90(3):177-180
pubmed: 29262988
Diagn Microbiol Infect Dis. 2018 Dec;92(4):294-298
pubmed: 30077505
Med Mal Infect. 2019 Feb;49(1):59-62
pubmed: 30446349
Open Forum Infect Dis. 2019 Apr 26;6(6):ofz192
pubmed: 31205973

Auteurs

Martin Martinot (M)

Infectious and Tropical Diseases, Department Medecine E, Hôpitaux Civils de Colmar, Colmar, France.

Valentin Greigert (V)

Infectious and Tropical Diseases, Department Medecine E, Hôpitaux Civils de Colmar, Colmar, France.
Parasitology Department, Strasbourg University, Strasbourg, France.

Simon Gravier (S)

Infectious and Tropical Diseases, Department Medecine E, Hôpitaux Civils de Colmar, Colmar, France.

Stephane Klein (S)

Infectious and Tropical Diseases, Department Medecine E, Hôpitaux Civils de Colmar, Colmar, France.

Magali Eyriey (M)

Clinical Research Department Hôpitaux Civils de Colmar, Colmar, France.

Anne Pachart (A)

Clinical Research Department Hôpitaux Civils de Colmar, Colmar, France.

Jean-Daniel Kaiser (JD)

Pharmacy Department, Hôpitaux Civils de Colmar, Colmar, France.

Mahsa Mohseni Zadeh (MM)

Infectious and Tropical Diseases, Department Medecine E, Hôpitaux Civils de Colmar, Colmar, France.

Dominique De Briel (D)

Microbiology Department, Hôpitaux Civils de Colmar, Colmar, France.

Yannick Gottwalles (Y)

Emergency Department, Hôpitaux Civils de Colmar, Colmar, France.

Eric Thibaud (E)

Emergency Department, Hôpitaux Civils de Colmar, Colmar, France.

Classifications MeSH